{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:06:38Z","timestamp":1785247598930,"version":"3.55.0"},"reference-count":6,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Emerging Drugs"],"published-print":{"date-parts":[[2021,10,2]]},"DOI":"10.1080\/14728214.2021.2004694","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T05:06:26Z","timestamp":1636434386000},"page":"433-434","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Resiquimod: a new topical immune-response modifier for the treatment of actinic keratosis"],"prefix":"10.1080","volume":"26","author":[{"given":"Morgan A.","family":"Farr","sequence":"first","affiliation":[{"name":"School of Medicine, Baylor College of Medicine, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas P.","family":"Joshi","sequence":"additional","affiliation":[{"name":"School of Medicine, Baylor College of Medicine, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2020.1730810"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/48.6.751"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14147"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17436"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17124"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08615.x"}],"container-title":["Expert Opinion on Emerging Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728214.2021.2004694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T07:05:28Z","timestamp":1654153528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728214.2021.2004694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,2]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10,2]]}},"alternative-id":["10.1080\/14728214.2021.2004694"],"URL":"https:\/\/doi.org\/10.1080\/14728214.2021.2004694","relation":{},"ISSN":["1472-8214","1744-7623"],"issn-type":[{"value":"1472-8214","type":"print"},{"value":"1744-7623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-07-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}